Benzonatate
- Product NDC
- 42291-164
- 11-digit product format
- 422910164
- Labeler code
- 42291
- Product ID
- 42291-164_a82118a6-18b5-4a8b-e053-2a95a90adb1a
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Benzonatate
- Dosage form
- CAPSULE, LIQUID FILLED
- Route
- ORAL
- Labeler
- AvKARE
- Application
- ANDA040682
- Marketing category
- ANDA
- Marketing start
- 2016-03-15
- Marketing end
- 0000-00-00
- Substance
- BENZONATATE
- Active strength
- 100 mg/1
- Pharmacologic classes
- Decreased Tracheobronchial Stretch Receptor Activity [PE],Non-narcotic Antitussive [EPC]
- NDC exclude flag
- No
- Listing certified through
- 2021-12-31
- Current FDA listing
- Historical FDA.report record
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 42291-164-01 | 42291016401 | 100 CAPSULE, LIQUID FILLED in 1 BOTTLE (42291-164-01) | 2016-03-15 | 0000-00-00 | No | No | Current |
| 42291-164-50 | 42291016450 | 500 CAPSULE, LIQUID FILLED in 1 BOTTLE (42291-164-50) | 2016-03-15 | 0000-00-00 | No | No | Current |